Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumour markers

H S Pandha1, J Waxman

  • 1Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

QJM : Monthly Journal of the Association of Physicians
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Tumour markers are crucial for cancer management, aiding in diagnosis, staging, and prognosis. Recent advancements include oncogenes and their products, enabling more specific cancer tests.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Oncogene·2026
Same author

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Science in Focus - Oncolytic Viruses: New Multifunctional Immunotherapeutics.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.

Gene therapy·2016
Same author

Circulating microRNAs as potential new biomarkers for prostate cancer.

British journal of cancer·2013
Same author

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.

Oncogene·2013
Same journal

Elevated circulating lactate in late-stage melanoma patients.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Response to letter from Mr. Yudai Kaneda entitled "Patient Preference and Generalisability in a Trial of Cheek Acupuncture for Stress Urinary Incontinence" (QJM-2026-999).

QJM : monthly journal of the Association of Physicians·2026
Same journal

Trends in mortality of people on dialysis in England and Wales over the last 15 years.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026
See all related articles

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Tumour markers are integral to modern oncology.
  • Their applications span diagnosis, staging, and prognosis across various cancers.

Purpose of the Study:

  • To highlight the expanding role of tumour markers.
  • To discuss the inclusion of oncogenes and oncogene products.

Main Methods:

  • Review of recent advancements in tumour marker research.
  • Analysis of the impact of oncogenes on cancer diagnostics.

Main Results:

  • Tumour markers are essential tools in cancer care.
  • Oncogenes and their products represent a new frontier.

Conclusions:

  • Expanded definitions of tumour markers offer improved specificity.
  • These advancements enhance the management of cancer patients.